Bell, Robert D. – Trademark Portfolio

Entity Type: 01

Bell, Robert D. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OVATION and TRIPLE B OINTMENT THE ALL IN ONE OINTMENT. The owner is based in Rosewell, NM.

901 Mason

Rosewell, NM 88201

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bell, Robert D.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Bell, Robert D. have?

Bell, Robert D. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Bell, Robert D. file in?

Bell, Robert D. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Bell, Robert D.'s most well-known trademarks?

Bell, Robert D.'s registered trademark portfolio includes well-known marks such as OVATION and TRIPLE B OINTMENT THE ALL IN ONE OINTMENT. These are among 2 currently registered trademarks in the portfolio.

What is Bell, Robert D.'s trademark registration success rate?

Bell, Robert D. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.